Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascale Zwicky

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Nature Immunology|February 15, 2024
IL-23 stabilizes an effector T<sub>reg</sub> cell program in the tumor microenvironmentTobias Wertheimer, Pascale Zwicky, Lukas Rindlisbacher, et al.
Acta Neuropathologica|March 28, 2021
Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signatureFlorian Ingelfinger, Sinduya Krishnarajah, Michael Kramer, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored ImmunotherapyRishita Chatterjee, Arturo Simoni-Nieves, An Truong, et al.
Cell|December 22, 2023
Time-resolved single-cell transcriptomics defines immune trajectories in glioblastomaDaniel Kirschenbaum, Ken Xie, Florian Ingelfinger, et al.
The Journal of Investigative Dermatology|March 15, 2023
S100A9 Drives the Chronification of Psoriasiform Inflammation by Inducing IL-23/Type 3 ImmunityBruno Marcel Silva de Melo, Flávio Protásio Veras, Pascale Zwicky, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Nature Immunology|February 15, 2024
IL-23 stabilizes an effector T<sub>reg</sub> cell program in the tumor microenvironmentTobias Wertheimer, Pascale Zwicky, Lukas Rindlisbacher, et al.
Acta Neuropathologica|March 28, 2021
Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signatureFlorian Ingelfinger, Sinduya Krishnarajah, Michael Kramer, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored ImmunotherapyRishita Chatterjee, Arturo Simoni-Nieves, An Truong, et al.
Cell|December 22, 2023
Time-resolved single-cell transcriptomics defines immune trajectories in glioblastomaDaniel Kirschenbaum, Ken Xie, Florian Ingelfinger, et al.
The Journal of Investigative Dermatology|March 15, 2023
S100A9 Drives the Chronification of Psoriasiform Inflammation by Inducing IL-23/Type 3 ImmunityBruno Marcel Silva de Melo, Flávio Protásio Veras, Pascale Zwicky, et al.
Pageof 3